Site icon Dermcast.live

IL-17 Inhibitor Updates: Defining Their Role in the Management of Inflammatory Conditions

Faculty: Mark Lebwohl, MD

Psoriasis is a chronic, immune-mediated, multi-system inflammatory skin disease conventionally treated with topical corticosteroids and assorted systemic medications including biologics. Rapid expansion in psoriasis treatment options holds great promise for patients with psoriasis who continue to struggle with symptoms or feel dissatisfied with treatment options. Join Mark Lebwohl, MD, as he discusses the availability of novel agents and the differences among these agents and their appropriate clinical use among patients with psoriasis.

At the end of this podcast, participants will be able to:

Exit mobile version